Literature DB >> 9266155

Advances in hereditary spastic paraplegia.

J K Fink1.   

Abstract

Hereditary spastic paraplegia refers to a group of clinically similar disorders whose primary feature is insidiously progressive lower extremity weakness and spasticity. Hereditary spastic paraplegia is genetically diverse: loci for autosomal recessive (chromosome 8p), autosomal dominant (chromosome 2p, 14q, and 15q), and x-linked hereditary spastic paraplegia have been identified. The existence of hereditary spastic paraplegia families for whom the disorder is unlinked to these loci indicates the existence of additional, as yet undiscovered, hereditary spastic paraplegia loci. Hereditary spastic paraplegia exhibits axonal degeneration that is maximal at the terminal portions of the longest central nervous system axons. Efforts to positionally clone the hereditary spastic paraplegia gene are in progress.

Entities:  

Mesh:

Year:  1997        PMID: 9266155     DOI: 10.1097/00019052-199708000-00006

Source DB:  PubMed          Journal:  Curr Opin Neurol        ISSN: 1350-7540            Impact factor:   5.710


  11 in total

1.  A new locus for autosomal dominant pure spastic paraplegia, on chromosome 2q24-q34.

Authors:  B Fontaine; C S Davoine; A Dürr; C Paternotte; I Feki; J Weissenbach; J Hazan; A Brice
Journal:  Am J Hum Genet       Date:  2000-02       Impact factor: 11.025

2.  Identification and expression analysis of spastin gene mutations in hereditary spastic paraplegia.

Authors:  I K Svenson; A E Ashley-Koch; P C Gaskell; T J Riney; W J Cumming; H M Kingston; E L Hogan; R M Boustany; J M Vance; M A Nance; M A Pericak-Vance; D A Marchuk
Journal:  Am J Hum Genet       Date:  2001-04-16       Impact factor: 11.025

3.  A new locus for autosomal recessive spastic paraplegia associated with mental retardation and distal motor neuropathy, SPG14, maps to chromosome 3q27-q28.

Authors:  G Vazza; M Zortea; F Boaretto; G F Micaglio; V Sartori; M L Mostacciuolo
Journal:  Am J Hum Genet       Date:  2000-06-30       Impact factor: 11.025

4.  Spastin, the most commonly mutated protein in hereditary spastic paraplegia interacts with Reticulon 1 an endoplasmic reticulum protein.

Authors:  Ashraf U Mannan; Johann Boehm; Simone M Sauter; Anne Rauber; Paula C Byrne; Juergen Neesen; Wolfgang Engel
Journal:  Neurogenetics       Date:  2006-04-07       Impact factor: 2.660

5.  Subcellular localization of spastin: implications for the pathogenesis of hereditary spastic paraplegia.

Authors:  Ingrid K Svenson; Mark T Kloos; Amy Jacon; Carol Gallione; April C Horton; Margaret A Pericak-Vance; Michael D Ehlers; Douglas A Marchuk
Journal:  Neurogenetics       Date:  2005-09-28       Impact factor: 2.660

6.  Mutations in the KIAA0196 gene at the SPG8 locus cause hereditary spastic paraplegia.

Authors:  Paul N Valdmanis; Inge A Meijer; Annie Reynolds; Adrienne Lei; Patrick MacLeod; David Schlesinger; Mayana Zatz; Evan Reid; Patrick A Dion; Pierre Drapeau; Guy A Rouleau
Journal:  Am J Hum Genet       Date:  2006-12-01       Impact factor: 11.025

7.  Intragenic modifiers of hereditary spastic paraplegia due to spastin gene mutations.

Authors:  Ingrid K Svenson; Mark T Kloos; P Craig Gaskell; Martha A Nance; James Y Garbern; Shin-ichi Hisanaga; Margaret A Pericak-Vance; Allison E Ashley-Koch; Douglas A Marchuk
Journal:  Neurogenetics       Date:  2004-07-10       Impact factor: 2.660

8.  Novel locus for autosomal dominant hereditary spastic paraplegia, on chromosome 8q.

Authors:  P Hedera; S Rainier; D Alvarado; X Zhao; J Williamson; B Otterud; M Leppert; J K Fink
Journal:  Am J Hum Genet       Date:  1999-02       Impact factor: 11.025

9.  Autosomal dominant hereditary spastic paraplegia: report of a large Italian family with R581X spastin mutation.

Authors:  P Aridon; P Ragonese; M De Fusco; D Lo Coco; G Salemi; G Casari; G Savettieri
Journal:  Neurol Sci       Date:  2007-08-10       Impact factor: 3.307

10.  Axonal degeneration in paraplegin-deficient mice is associated with abnormal mitochondria and impairment of axonal transport.

Authors:  Fatima Ferreirinha; Angelo Quattrini; Marinella Pirozzi; Valentina Valsecchi; Giorgia Dina; Vania Broccoli; Alberto Auricchio; Fiorella Piemonte; Giulia Tozzi; Laura Gaeta; Giorgio Casari; Andrea Ballabio; Elena I Rugarli
Journal:  J Clin Invest       Date:  2004-01       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.